WithdrawnN/Aketamine

Low Dose Ketamine Infusion for the Treatment of Resistant Depression

NCT ID

NCT04283058

Start Date

2020-06-29

Est. Completion

2020-12-29

About This Study

The purpose of this investigator-initiated observational study is to examine how low Ketamine infusion treatments impact antidepressant and anti-suicidal effects for refractory and non-refractory depression.

Conditions Studied

Depression

Interventions

•Ketamine

Eligibility

Age:18 Years - 89 Years

Healthy Volunteers:Yes

View full eligibility criteria

Inclusion Criteria:

* treatment resistant depression

Exclusion Criteria:

* Patients excluded by SICU/ER attending for treatment based on the following relative contraindications:

  1. Coronary artery disease
  2. Increased intraocular pressure (glaucoma)
  3. Increased intracranial pressure
  4. Uncontrolled hypertension
  5. Kidney dysfunction
  6. Liver dysfunction
  7. Cardiac decompensation
  8. Psychotic disorders (needs further evaluation)

Study Locations (1)

Loma Linda University Medical Center

Loma Linda, California, United States